Seeking value primarily in developed markets worldwide

The Fund invests primarily in common stocks of companies in developed countries located outside the US and of companies in the US. Normally, the Fund invests the majority of its total assets in companies that pay dividends or repurchase their shares. The Fund may invest up to 20% of its total assets in companies located in emerging (less developed) markets. Under normal circumstances, the Fund will invest at least 40% of its total assets in companies located in a number of countries outside the US. The Fund’s investment objective is to seek long-term growth of capital and income.

YTD Return*
+24.45%
Nav*
$15.37, +0.01
Inception
January 31, 2011
Cusip
14949P604
Benchmark
MSCI ACWI
Minimum Investment
$5,000
Sales Charge
None
Gross Expense Ratio
1.43%
Net Expense Ratio
1.10%
*As of September 17, 2025
**Contractual fee waivers are in effect until 1/31/2026.

Strategy overview

The portfolio managers discuss our Global Value strategy.

Portfolio managers

Fundamental Portfolio Manager
Fundamental Portfolio Manager
President
Head of Fundamental Research
Fundamental Portfolio Manager
Chief Executive Officer
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager

Performance

Table Header QTD YTD 1 year3 years5 years10 years Since inception
Fund 6.2%21.1%20.3%23.8%18.2%9.8%9.1%
MSCI ACWI 3.9%14.3%15.8%17.7%12.0%11.1%9.5%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Fund 6.2%21.1%20.3%23.8%18.2%9.8%9.1%
MSCI ACWI 3.9%14.3%15.8%17.7%12.0%11.1%9.5%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Fund 10.5%14.1%19.9%21.5%18.0%8.7%8.8%
MSCI ACWI 11.5%10.0%16.2%17.3%13.7%10.0%9.3%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Fund 10.5%14.1%19.9%21.5%18.0%8.7%8.8%
MSCI ACWI 11.5%10.0%16.2%17.3%13.7%10.0%9.3%
Table Header 2024202320222021202020192018201720162015201420132012
Fund 12.5%29.4%-12.3%16.1%7.2%21.1%-11.2%17.6%7.4%-6.6%5.2%29.0%16.2%
MSCI ACWI 17.5%22.2%-18.4%18.5%16.3%26.6%-9.4%24.0%7.9%-2.4%4.2%22.8%16.1%
Table Header
Fund
MSCI ACWI
2024202320222021202020192018201720162015201420132012
12.5%29.4%-12.3%16.1%7.2%21.1%-11.2%17.6%7.4%-6.6%5.2%29.0%16.2%
17.5%22.2%-18.4%18.5%16.3%26.6%-9.4%24.0%7.9%-2.4%4.2%22.8%16.1%

Portfolio (as of August 31, 2025)

Benchmark: MSCI ACWI
Asset Allocation
Table Header Fund
Stocks 96.2%
Cash 3.8%
Fund Characteristics
Table Header Fund Benchmark
No. of holdings 55 2509
Weighted avg. market cap (US $MM) $158,547 $760,115
FY2 price/earnings 13.4 18.1
Price/book value 2.0 3.4
Net assets $11,387,199 -
TOP 10 HOLDINGS
Security Country Percent
Kering SA France 4.2%
Samsung Electronics Co., Ltd. South Korea 4.0%
Alphabet, Inc. United States 3.8%
Alstom SA France 3.2%
Reckitt Benckiser Group Plc United Kingdom 3.1%
Rolls-Royce Holdings Plc United Kingdom 3.0%
Renesas Electronics Corp. Japan 2.8%
Carnival Corp. United States 2.7%
Infineon Technologies AG Germany 2.6%
AstraZeneca PLC United Kingdom 2.5%

A “weighted average” measures a characteristic by the market capitalization of each stock. Price/book ratio is the weighted average of the price/book ratios of all the stocks in a portfolio. The P/B ratio of a company is calculated by dividing the market price of its stock by the company’s per-share book value. The price/earnings ratio is the weighted average of the price/earnings ratios of the stocks in a portfolio. The FY2 P/E ratio is a forward P/E ratio using a next-twenty-four months EPS estimate in the denominator.

Holdings are subject to change.

SECTOR WEIGHTS
Sector Fund Benchmark
Information Technology 23.0% 26.6%
Financials 15.2% 17.7%
Consumer Discretionary 11.9% 10.4%
Health Care 11.5% 8.5%
Industrials 11.1% 11.0%
Communication Services 10.3% 8.6%
Consumer Staples 6.7% 5.6%
Materials 5.1% 3.4%
Utilities 2.0% 2.6%
Real Estate 1.6% 1.9%
Energy 1.0% 3.6%
TOP 10 COUNTRIES
Country Fund Benchmark
United States 42.8% 64.6%
United Kingdom 17.0% 3.3%
France 8.1% 2.4%
Japan 7.6% 4.9%
Germany 4.9% 2.2%
Netherlands 4.8% 1.0%
South Korea 4.0% 1.1%
China 2.0% 3.2%
Canada 2.0% 2.9%
Sweden 1.5% 0.8%
Regional Allocation
  • North America 44.8%
  • Euro 18.6%
  • Europe - Other 18.5%
  • Pacific 7.6%
  • Emerging Asia 6.0%
  • Emerging Europe, Middle East, Africa 0.7%

Commentary (As of August 31, 2025)

Highlights

  • Global equities advanced in August, supported by strong corporate earnings, rising expectations for a Fed rate cut, and improving trade sentiment.
  • Fiscal pressure on the UK and France has eroded investor confidence and added upward pressure to their sovereign bond yields. Market discipline should force their respective governments to agree this year to spending cuts and revenue increases.
  • Causeway’s global and international value portfolios focus on identifying undervalued stocks rather than positioning around macroeconomic trends. Given the valuation gap between US and non-US markets, we aim to find some of the most compelling investment opportunities across international markets.

Portfolio Attribution

The Causeway Global Value Fund ("Fund"), on a net asset value basis, outperformed the Index during the month, due primarily to stock selection. On a gross return basis, Fund holdings in the semiconductors & semi equipment and media & entertainment industry groups, as well as an overweight position in the consumer durables & apparel industry group, contributed to relative performance. Holdings in the technology hardware & equipment, materials, and consumer services industry groups offset some of the outperformance compared to the Index. The top contributor to return was technology conglomerate, Alphabet, Inc. (United States). Other notable contributors included multinational luxury conglomerate, Kering SA (France), and medical device producer, Zimmer Biomet Holdings, Inc. (United States). The largest detractor was enterprise management software provider, Oracle Corp. (United States). Additional notable detractors included airport & rail station concessionaire, SSP Group Plc (United Kingdom), and electronic equipment manufacturer, Samsung Electronics Co., Ltd.(South Korea).

Investment Outlook

Fiscal pressure on the UK and France has eroded investor confidence and added upward pressure to their sovereign bond yields. Market discipline should force their respective governments to agree this year to spending cuts and revenue increases. Even Germany, whose leaders have committed to a sizable boost in defense spending, cannot meet its goals without reforming the social insurance system. For Europe overall, we currently anticipate substantial economic benefits to begin materializing in 2026, as both the public and private sectors intensify investments in defense, security, energy, and infrastructure. The region’s initiatives to harmonize regulations and establish a unified, liquid capital market have the potential to significantly accelerate innovation and drive sustained long-term economic growth. If European leaders implement the reforms proposed by Mario Draghi last year, our two-year price targets could prove conservative, particularly for portfolio holdings most sensitive to European economic growth. We continue to take a disciplined approach, favoring investments at current valuations rather than paying a premium for potential future positive developments.

Causeway’s global and international value portfolios focus on identifying undervalued stocks rather than positioning around macroeconomic trends. Given the valuation gap between US and non-US markets, we aim to find some of the most compelling investment opportunities across international markets. Our focus remains on identifying companies that offer durable value, characterized by pricing power, iconic brands, or robust product pipelines. Even the highest quality businesses can encounter temporary dislocations, which we view as opportunities to increase positions at attractive valuations. Recent external shocks have created such opportunities among select-high quality companies. The pharmaceutical industry faces a considerable list of challenges including US pricing, global trade restrictions, China’s economic slowdown, and uncertainties in drug pipelines. These challenges have created, in our view, value opportunities in some of the world’s top pharmaceutical firms where we remain confident in their ability to sustain cash flow, profit margins, and innovation over time. Across sectors, Causeway targets companies we believe are improving efficiency, driving earnings, and boosting cash flow.

Effective October 1, 2018, the Global Value Fund’s benchmark changed from the MSCI World Index (Gross) to the MSCI ACWI Index (Gross). Causeway believes that the MSCI ACWI Index (Gross), which includes emerging as well as developed markets, better represents the types of securities in which the strategy invests. The market commentary expresses the portfolio managers’ views as of the date of this report and should not be relied on as research or investment advice regarding any stock. These views and the Fund holdings and characteristics are subject to change. There is no guarantee that any forecasts made will come to pass. Any securities identified and described in this report do not represent all of the securities purchased, sold or recommended for client accounts. The reader should not assume that an investment in the securities identified was or will be profitable. Diversification does not protect against market loss. Current and future holdings are subject to risk. A company may reduce or eliminate its dividend, causing losses to a fund. International and emerging markets investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. Emerging markets and smaller companies involve additional risks and higher volatility.

Distributions

Table Header Dividends Short-term capital gains Long-term capital gains
2024 $0.1681 $1.0338 $1.8282
2023 $0.1176 $0.1241 $0.0609
2022 $0.0688 $0.0000 $0.0000
2021 $0.0596 $0.1541 $0.1704
2020 $0.1352 $0.0000 $0.0000
2019 $0.3207 $0.1359 $0.0305
2018 $0.1809 $0.2508 $1.2062
2017 $0.2082 $0.4167 $0.1330
2016 $0.1309 $0.0000 $0.0000
2015 $0.0931 $0.0000 $0.2089
2014 $0.1985 $0.3781 $0.5989
2013 $0.0921 $0.2969 $0.1573
2012 $0.0874 $0.0094 $0.0380
2011 $0.8360 $0.0000 $0.0000
2010 $0.0000 $0.0000 $0.0000
2009 $0.0000 $0.0000 $0.0000
2008 $0.0000 $0.0500 $0.0000

Distributions are per share. Distribution amounts are based on gains and losses realized and income earned by the Fund through October 31 (or earlier under certain circumstances).

Documents

Fund information:

Forms: